Stay updated on Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.

Latest updates to the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a new publication reference about variable-dose versus continuous-dose abrocitinib in moderate-to-severe atopic dermatitis to the Publications section. This expands the study's literature context for readers.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4. This reflects a minor update to the page's underlying software or documentation rather than changes to the visible study details.SummaryDifference0.0%

- Check27 days agoChange DetectedA new publication citation by Yosipovitch et al. is added to the Publications section, detailing a post hoc analysis of JADE COMPARE and JADE DARE related to itch relief and quality of life in atopic dermatitis. This expands the study's referenced literature and author attribution.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page’s footer release/version label was updated from Revision v3.5.2 to Revision v3.5.3, indicating a minor platform update rather than a change to the trial information.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.